Healthcare -
Biotechnology - NASDAQ - US
$ 11.2
1.08 %
$ 454 M
Market Cap
-2.24
P/E
KROS - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative KROS - Keros Therapeutics, Inc.
34.8 M
LAST VALUE
27.79%
2 YEAR CAGR
85.64%
5 YEAR CAGR
0.00%
10 YEAR CAGR